← Issue №9/ week of Aug 30, 2026/Endoscopy

Types of Self-Expandable Metal Stents for Palliative Drainage of Unresectable Extrahepatic Malignant Biliary Obstruction: A Network Meta-Analysis of Randomized Controlled Trials.

From GI Signals issue №9: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Endoscopy meta analysis · n=1,659 · Aug 29, 2026 · Endoscopy · IF 11.8

Types of Self-Expandable Metal Stents for Palliative Drainage of Unresectable Extrahepatic Malignant Biliary Obstruction: A Network Meta-Analysis of Randomized Controlled Trials.

New evidenceERCPmeta-analysisbiliary stricture
Clinical takeawayConsider UCSEMS for patients with intact gallbladder to minimize acute cholecystitis risk; otherwise, stent choice can be individualized based on other factors (e.g., tumor ingrowth prevention with FCSEMS).
What it foundNo significant differences in time to recurrent biliary obstruction (RBO), incidence of RBO, or overall survival between fully covered (FCSEMS), partially covered (PCSEMS), and uncovered SEMS (UCSEMS); FCSEMS had higher acute cholecystitis risk compared to UCSEMS in patients with an intact gallbladder.
ContextRefines prior observational data with RCT-only evidence: confirms no clear superiority in RBO or survival, but highlights gallbladder status as a key modifier for FCSEMS safety.
Emergingsuggested applicable standard· American College of Gastroenterology, 'Diagnosis and Management of Choledocholithiasis', 2019

Decision at stakethe choice of self-expandable metal stents for palliative drainage of unresectable extrahepatic malignant biliary obstruction

No single passage of this standard matched the paper closely enough to quote, so none is shown. The standard is cited above.

Our full summary of this standard

For right upper quadrant pain, characterize the pattern (acute vs chronic, post-meal vs unrelated, with vs without fever/jaundice) and triage acute red-flag presentations (Murphy sign, Charcot's triad, painless jaundice with weight loss, pregnancy with LFT/coagulation derangement) to the ED. Obtain labs (CBC, CMP with LFTs, lipase, urinalysis, pregnancy test in reproductive-age women) and RUQ ultrasound as first imaging, then direct further workup by ultrasound findings, cholecystectomy for acute cholecystitis, MRCP for suspected choledocholithiasis based on risk stratification (e.g., high-risk criteria including CBD dilation >6 mm, bilirubin >4 mg/dL, or gallstone pancreatitis), CCK-HIDA/GBEF for acalculous functional gallbladder disorder, and cross-sectional imaging for liver masses or other pathology.

American College of Gastroenterology, 'Diagnosis and Management of Choledocholithiasis', 2019 · reviewed 2026-07-21 ↗
Simadibrata DM … Chandrasekhara V · Endoscopy · IF 11.8 · PubMed ↗Permalink
← Read the whole of issue №9 Every paper GI Signals surfaces gets a page like this one. All issues